Clinical Microbiology Newsletter
Volume 30, Issue 3 , Pages 15-21, 1 February 2008

The Impact of Molecular Diagnostics on Women's Health

  • Melissa B. Miller, Ph.D., D(ABMM)

      Affiliations

    • Corresponding Author InformationMailing Address: Melissa B. Miller, Ph.D., UNC School of Medicine, Department of Pathology and Laboratory Medicine, Campus Box #7525, Chapel Hill, NC 27599-7525. Tel.: 919-966-3723. Fax: 919-966-0486

University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina

Abstract 

Molecular diagnostics has impacted nearly every discipline in the laboratory. Specifically, molecular infectious disease testing has revolutionized the diagnosis of viral infections, sexually transmitted infections, and emerging pathogens. The impact has been felt in a wide variety of patient populations, including HIV-infected individuals, transplant recipients, pediatrics, and women. This article reviews the impact of molecular diagnostics on women's health, including a discussion of public health indicators and molecular testing for group B streptococci, human papillomavirus, Neisseria gonorrhoeae and Chlamydia trachomatis, and HIV.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0196-4399(08)00005-6

doi:10.1016/j.clinmicnews.2008.01.004

Clinical Microbiology Newsletter
Volume 30, Issue 3 , Pages 15-21, 1 February 2008

Article Tools